Skip to main content

Table 2 Relationships between ANXA8 expression in epithelial ovarian cancer and clinicopathological parameters

From: Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins

Characteristics n Low High High positive rate (%) P-value
(−) (+) (++) (+++)
FIGO stage 0.006*
 I–II 35 6 9 8 12 57.14
 III–IV 46 2 5 21 18 84.78
Differentiation 0.401
 Well–moderate 38 3 9 13 13 68.42
 Poor 43 5 5 16 17 76.74
LN metastasis 0.414
 No 45 6 8 15 16 68.89
 Yes 19 0 4 8 7 78.95
 No lymphadenectomy 17 2 2 6 7 76.47
Pathologic type 0.673
 Serous 40 3 8 15 14 72.50
 Mucinous 9 1 3 3 2 55.56
 Endometrioid 11 2 1 3 5 72.72
 Clear cell carcinoma 8 0 1 2 5 87.50
 Poorly differentiated adenocarcinoma 13 2 1 6 4 76.92
  1. FIGO International Federation of Gynecology and Obstetrics, LN lymph node
  2. P < 0.05